Geistlich vallomix™
The first xenogeneic/allogeneic validated bone substitute1
Now we’re making it easier for you to combine two validated regenerative materials for restoring vital bone faster2 – with the proven long-term volume stability you rely on.
Bringing together the verified osteoinductivity of vallos® allograft1 with the volume stability of Geistlich Bio-Oss®.3-8
Conveniently packaged Geistlich vallomix™ contains Geistlich Bio-Oss® granules and vallos® granules or fibers. Together, these proven products bring optimal consistency and performance1-14 in demanding clinical situations.
Validated • Allograft • Osteoinductive • Selection
References:
- Compiled DCI Osteoinductivity Validation Summary_2020. (data on file)
- Robert A Wood & Brian L Mealey: J Periodontol. 2012 Mar;83(3):329-36. (Clinical Study)
- Piattelli M et al.: Int J Oral Maxillofac Implants 1999; 14 (6), 835-40. (Clinical Study).
- Sartori S et al.: Clin Oral Implants Res 2003; 14 (3), 369-72. (Clinical Study).
- Maiorana C et al.: Int J Periodontics Restorative Dent 2005; 25 (1), 19-25. (Clinical Study).
- Orsini G et al.: Oral Dis 2007; 13 (6), 586-93. (Clinical Study).
- Lindgren C et al.: Int J Oral Maxillofac Implants 2009; 24 (6), 1093-100. (Clinical Study).
- Mordenfeld A et al.: Clin Oral Implants Res 2010; 21 (9), 961-70. (Clinical Study).
- Serrano CA et al.: Implant Dent. 2018 Aug; 27(4):467-473. (Clinical Study).
- NCBI Pubmed, Month Year, Search term “Bio-Oss” (1208 hits) (Market research).
- Berglundh T & Lindhe J: Clin Oral Implants Res 1997; 8 (2), 117-24. (Preclincal Study).
- Weibrich G et al.: Mund Kiefer Gesichtschir 2000; 4 (3), 148-52. (Preclincal Study).
- Degidi M et al.: Oral Dis 2006; 12 (5), 469-75. (Clinical Study).
- Galindo-Moreno P et al.: Clin Oral Implants Res 2010; 21 (2), 221-7. (Clinical Study).
- Data on file, Geistlich Pharma AG, Switzerland
vallos® – Osteoinductive Potential
Verified vallos<sup>®</sup> granules and fibers are allogeneic bone grafts that have been demineralized to ensure high osteoinductive properties.1 A demineralized bone matrix has the advantage of turning over natural bone more rapidly but lacks the volume stability needed in a number of clinical situations.
The selection process of vallos<sup>®</sup> involves thorough review and validated lot testing to ensure:
- Consistent product quality1
- Verified osteoinductive potential, validated test method1
- Demineralized allografts have shown vital bone after 18-20 weeks2
References:
- Compiled DCI Osteoinductivity Validation Summary_2020. (data on file)
- Robert A Wood & Brian L Mealey: J Periodontol. 2012 Mar;83(3):329-36. (Clinical Study)
- Piattelli M et al.: Int J Oral Maxillofac Implants 1999; 14 (6), 835-40. (Clinical Study).
- Sartori S et al.: Clin Oral Implants Res 2003; 14 (3), 369-72. (Clinical Study).
- Maiorana C et al.: Int J Periodontics Restorative Dent 2005; 25 (1), 19-25. (Clinical Study).
- Orsini G et al.: Oral Dis 2007; 13 (6), 586-93. (Clinical Study).
- Lindgren C et al.: Int J Oral Maxillofac Implants 2009; 24 (6), 1093-100. (Clinical Study).
- Mordenfeld A et al.: Clin Oral Implants Res 2010; 21 (9), 961-70. (Clinical Study).
- Serrano CA et al.: Implant Dent. 2018 Aug; 27(4):467-473. (Clinical Study).
- NCBI Pubmed, Month Year, Search term “Bio-Oss” (1208 hits) (Market research).
- Berglundh T & Lindhe J: Clin Oral Implants Res 1997; 8 (2), 117-24. (Preclincal Study).
- Weibrich G et al.: Mund Kiefer Gesichtschir 2000; 4 (3), 148-52. (Preclincal Study).
- Degidi M et al.: Oral Dis 2006; 12 (5), 469-75. (Clinical Study).
- Galindo-Moreno P et al.: Clin Oral Implants Res 2010; 21 (2), 221-7. (Clinical Study).
- Data on file, Geistlich Pharma AG, Switzerland
Geistlich Bio-Oss® – Volume Stability
Geistlich Bio-Oss® is the leading xenogeneic bone substitute worldwide, with more than 35 years of scientific validation. It is the ideal biomaterial that consistently maintains bone volume over time.3-8
With each vial of Geistlich Bio-Oss®, you are assured a treatment solution with:
- Demonstrated clinical success9
- Optimal scaffold for vascularization and new bone formation10-13
- Long-term volume stability3-8
References:
- Compiled DCI Osteoinductivity Validation Summary_2020. (data on file)
- Robert A Wood & Brian L Mealey: J Periodontol. 2012 Mar;83(3):329-36. (Clinical Study)
- Piattelli M et al.: Int J Oral Maxillofac Implants 1999; 14 (6), 835-40. (Clinical Study).
- Sartori S et al.: Clin Oral Implants Res 2003; 14 (3), 369-72. (Clinical Study).
- Maiorana C et al.: Int J Periodontics Restorative Dent 2005; 25 (1), 19-25. (Clinical Study).
- Orsini G et al.: Oral Dis 2007; 13 (6), 586-93. (Clinical Study).
- Lindgren C et al.: Int J Oral Maxillofac Implants 2009; 24 (6), 1093-100. (Clinical Study).
- Mordenfeld A et al.: Clin Oral Implants Res 2010; 21 (9), 961-70. (Clinical Study).
- Serrano CA et al.: Implant Dent. 2018 Aug; 27(4):467-473. (Clinical Study).
- NCBI Pubmed, Month Year, Search term “Bio-Oss” (1208 hits) (Market research).
- Berglundh T & Lindhe J: Clin Oral Implants Res 1997; 8 (2), 117-24. (Preclincal Study).
- Weibrich G et al.: Mund Kiefer Gesichtschir 2000; 4 (3), 148-52. (Preclincal Study).
- Degidi M et al.: Oral Dis 2006; 12 (5), 469-75. (Clinical Study).
- Galindo-Moreno P et al.: Clin Oral Implants Res 2010; 21 (2), 221-7. (Clinical Study).
- Data on file, Geistlich Pharma AG, Switzerland
CAUTION: Federal law restricts these devices to sale by or on the order of a dentist or physician.
